Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

v3.8.0.1
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
REVENUES    
Real property rental $ 828,663
Medical related consulting services - related parties 222,611 616,446
Development services and sales of developed products 26,276
Total Revenues 1,077,550 616,446
COSTS AND EXPENSES    
Real property operating expenses 542,371
Medical related consulting services - related parties 272,400 73,066
Development services and sales of developed products 15,016
Total Costs and Expenses 829,787 73,066
REAL PROPERTY OPERATING INCOME 286,292
GROSS (LOSS) PROFIT FROM MEDICAL RELATED CONSULTING SERVICES (49,789) 543,380
GROSS PROFIT FROM DEVELOPMENT SERVICES AND SALES OF DEVELOPED PRODUCTS 11,260
OTHER OPERATING EXPENSES:    
Selling expense 15,253 6,894
Compensation and related benefits 1,291,183 10,088
Professional fees 1,033,308 395,780
Other general and administrative 464,544 53,685
Impairment loss 1,321,338
Total Other Operating Expenses 4,125,626 466,447
(LOSS) INCOME FROM OPERATIONS (3,877,863) 76,933
OTHER INCOME (EXPENSE)    
Interest income 1,370 575
Interest expense (138,110)
Foreign currency transaction loss (57,244)
Grant income 22,202
Total Other (Expense) Income, net (171,782) 575
(LOSS) INCOME BEFORE INCOME TAXES (4,049,645) 77,508
INCOME TAXES 21,927
NET (LOSS) INCOME (4,049,645) 55,581
LESS: NET (LOSS) INCOME ATTRIBUTABLE TO NON-CONTROLLING INTEREST (585,360)
NET (LOSS) INCOME ATTRIBUTABLE TO AVALON GLOBOCARE CORP. COMMON SHAREHOLDERS (3,464,285) 55,581
COMPREHENSIVE (LOSS)    
NET (LOSS) INCOME (4,049,645) 55,581
Unrealized foreign currency translation gain (loss) 2,540 (94,568)
COMPREHENSIVE LOSS (4,047,105) (38,987)
LESS: COMPREHENSIVE LOSS ATTRIBUTABLE TO NON-CONTROLLING INTEREST (585,394)
COMPREHENSIVE LOSS ATTRIBUTABLE TO AVALON GLOBOCARE CORP. COMMON SHAREHOLDERS $ (3,461,711) $ (38,987)
NET (LOSS) INCOME PER COMMON SHARE ATTRIBUTABLE TO AVALON GLOBOCARE CORP. COMMON SHAREHOLDERS:    
Basic and diluted $ (0.05) $ 0.00
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING:    
Basic and diluted 65,033,472 51,139,475